Form 4: SANUWAVE CEO Acquires 1,540 Stock Options

SANUWAVE Health, Inc. CEO Morgan C. Frank acquired 1,540 stock options with an exercise price of $29.84, fully vested at grant.

Summary

• Morgan C. Frank, the Chief Executive Officer and a Director of SANUWAVE Health, Inc. (SNVW), acquired 1,540 stock options.
• The stock options have an exercise price of $29.84 per share.
• The transaction date for the option grant was December 31, 2025.
• These options were fully vested at the grant date, as stated in the explanation of responses.
• The options are exercisable as of December 31, 2025, and have an expiration date of December 31, 2030.
• Following this reported transaction, Mr. Frank directly beneficially owns 1,540 derivative securities.

Sentiment

Score: 7

Explanation: The acquisition of stock options by a CEO is generally viewed positively as it aligns management's interests with shareholders, indicating confidence in future growth. However, it's a routine insider transaction and not a major strategic announcement.

Positives

• The acquisition of stock options by the CEO aligns his financial interests with those of the shareholders, potentially signaling confidence in the company's future performance and growth prospects.
• The options were fully vested at the grant date, providing immediate ownership rights and removing future vesting conditions.

Future Outlook

This filing does not contain forward-looking statements or guidance, as it is a report of an insider transaction.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: Potentially positive, as the CEO's increased stake through options aligns his incentives with share price appreciation.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Keywords

SANUWAVE Health, SNVW, Stock Options, CEO, Insider Trading, Executive Compensation, Form 4, Beneficial Ownership